Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Axonal Transport | 3 | 2020 | 38 | 1.300 |
Why?
|
| Molecular Imaging | 2 | 2014 | 185 | 0.840 |
Why?
|
| Retinal Diseases | 1 | 2020 | 179 | 0.620 |
Why?
|
| Retina | 1 | 2020 | 532 | 0.570 |
Why?
|
| Radiography, Dual-Energy Scanned Projection | 1 | 2015 | 54 | 0.490 |
Why?
|
| Intracranial Hemorrhages | 1 | 2015 | 121 | 0.470 |
Why?
|
| Calcinosis | 1 | 2015 | 423 | 0.400 |
Why?
|
| Spinal Cord Injuries | 1 | 2014 | 374 | 0.390 |
Why?
|
| Neuroimaging | 1 | 2013 | 403 | 0.370 |
Why?
|
| Spheroids, Cellular | 1 | 2008 | 222 | 0.310 |
Why?
|
| Tetanus Toxin | 3 | 2020 | 38 | 0.310 |
Why?
|
| Microscopy, Confocal | 2 | 2009 | 663 | 0.290 |
Why?
|
| Radiation Injuries | 1 | 2014 | 1411 | 0.290 |
Why?
|
| Oncogene Proteins, Viral | 2 | 2003 | 133 | 0.260 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2021 | 7551 | 0.230 |
Why?
|
| Papillomaviridae | 3 | 2003 | 624 | 0.220 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2003 | 323 | 0.210 |
Why?
|
| Karyopherins | 1 | 2003 | 136 | 0.200 |
Why?
|
| Cell Nucleus | 3 | 2003 | 1620 | 0.190 |
Why?
|
| Rats, Inbred BN | 1 | 2020 | 34 | 0.190 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 1162 | 0.190 |
Why?
|
| N-Methylaspartate | 1 | 2020 | 50 | 0.190 |
Why?
|
| Proteins | 1 | 2008 | 1963 | 0.180 |
Why?
|
| Carbon-13 Magnetic Resonance Spectroscopy | 1 | 2019 | 13 | 0.180 |
Why?
|
| Endocytosis | 1 | 2020 | 225 | 0.170 |
Why?
|
| Retinal Ganglion Cells | 1 | 2020 | 144 | 0.170 |
Why?
|
| Axons | 1 | 2020 | 403 | 0.150 |
Why?
|
| Glycolysis | 1 | 2019 | 519 | 0.140 |
Why?
|
| Synapses | 1 | 2020 | 509 | 0.140 |
Why?
|
| Spinal Cord | 3 | 2014 | 690 | 0.130 |
Why?
|
| Repressor Proteins | 1 | 2003 | 1664 | 0.130 |
Why?
|
| Calcium | 1 | 2021 | 1537 | 0.130 |
Why?
|
| Glioma | 2 | 2019 | 1963 | 0.120 |
Why?
|
| Mice, Inbred BALB C | 2 | 2014 | 2314 | 0.110 |
Why?
|
| Organelles | 1 | 2012 | 40 | 0.100 |
Why?
|
| alpha Karyopherins | 2 | 2003 | 13 | 0.100 |
Why?
|
| Genetic Techniques | 1 | 2012 | 130 | 0.100 |
Why?
|
| Fluorescent Dyes | 2 | 2012 | 459 | 0.100 |
Why?
|
| Adenoviruses, Simian | 1 | 2010 | 4 | 0.100 |
Why?
|
| Neurons | 2 | 2012 | 2287 | 0.090 |
Why?
|
| Disease Models, Animal | 2 | 2020 | 7222 | 0.090 |
Why?
|
| Capsid | 2 | 2000 | 103 | 0.090 |
Why?
|
| Organoplatinum Compounds | 1 | 2012 | 702 | 0.090 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2015 | 925 | 0.090 |
Why?
|
| Phantoms, Imaging | 1 | 2015 | 1271 | 0.080 |
Why?
|
| Luminescent Agents | 1 | 2008 | 18 | 0.080 |
Why?
|
| Carrier Proteins | 2 | 2012 | 2022 | 0.080 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2012 | 393 | 0.080 |
Why?
|
| Biomarkers | 1 | 2020 | 5047 | 0.080 |
Why?
|
| Receptors, Cell Surface | 1 | 2012 | 862 | 0.080 |
Why?
|
| Nuclear Localization Signals | 3 | 2003 | 46 | 0.080 |
Why?
|
| Radiopharmaceuticals | 1 | 2013 | 1301 | 0.080 |
Why?
|
| Brain Neoplasms | 2 | 2019 | 4849 | 0.080 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2015 | 1648 | 0.080 |
Why?
|
| Peptide Fragments | 2 | 2012 | 1271 | 0.080 |
Why?
|
| Luminescent Proteins | 1 | 2008 | 289 | 0.080 |
Why?
|
| Animals | 7 | 2020 | 59536 | 0.080 |
Why?
|
| Contrast Media | 1 | 2013 | 1472 | 0.070 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2008 | 376 | 0.070 |
Why?
|
| Green Fluorescent Proteins | 1 | 2008 | 694 | 0.070 |
Why?
|
| Genes, Reporter | 1 | 2008 | 798 | 0.070 |
Why?
|
| beta Karyopherins | 2 | 2003 | 36 | 0.070 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 4744 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2010 | 1694 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 6009 | 0.060 |
Why?
|
| HeLa Cells | 3 | 2003 | 1643 | 0.060 |
Why?
|
| Neoplasms | 1 | 2008 | 15193 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 1 | 2008 | 3101 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 1 | 2008 | 5395 | 0.050 |
Why?
|
| Whole Body Imaging | 2 | 2012 | 114 | 0.050 |
Why?
|
| Pyruvic Acid | 1 | 2019 | 133 | 0.040 |
Why?
|
| Hemorrhage | 1 | 2021 | 712 | 0.040 |
Why?
|
| Humans | 8 | 2021 | 261506 | 0.030 |
Why?
|
| Amino Acid Sequence | 3 | 2012 | 4233 | 0.030 |
Why?
|
| Feasibility Studies | 1 | 2019 | 2292 | 0.030 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 6089 | 0.030 |
Why?
|
| Cell-Penetrating Peptides | 1 | 2012 | 4 | 0.030 |
Why?
|
| Mice | 4 | 2019 | 34495 | 0.030 |
Why?
|
| DNA | 1 | 2000 | 2693 | 0.030 |
Why?
|
| Mice, Nude | 1 | 2019 | 4307 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2012 | 186 | 0.030 |
Why?
|
| Bacteriophages | 1 | 2012 | 71 | 0.020 |
Why?
|
| Biological Transport | 1 | 2012 | 597 | 0.020 |
Why?
|
| Female | 4 | 2019 | 141928 | 0.020 |
Why?
|
| Ice Cover | 1 | 2010 | 4 | 0.020 |
Why?
|
| Factor X | 1 | 2010 | 10 | 0.020 |
Why?
|
| Protein Binding | 2 | 2012 | 3438 | 0.020 |
Why?
|
| Kupffer Cells | 1 | 2010 | 42 | 0.020 |
Why?
|
| Serotyping | 1 | 2010 | 166 | 0.020 |
Why?
|
| Quinolinium Compounds | 1 | 2009 | 4 | 0.020 |
Why?
|
| Male | 1 | 2020 | 123000 | 0.020 |
Why?
|
| Lymphatic System | 1 | 2009 | 64 | 0.020 |
Why?
|
| Adenoviruses, Human | 1 | 2010 | 181 | 0.020 |
Why?
|
| Dimerization | 2 | 2000 | 304 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 14289 | 0.020 |
Why?
|
| Sciatic Nerve | 1 | 2009 | 112 | 0.020 |
Why?
|
| Ligands | 1 | 2012 | 995 | 0.020 |
Why?
|
| Injections, Intramuscular | 1 | 2009 | 255 | 0.020 |
Why?
|
| Gene Targeting | 1 | 2010 | 292 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 2 | 2010 | 6942 | 0.020 |
Why?
|
| Species Specificity | 1 | 2010 | 777 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2012 | 850 | 0.020 |
Why?
|
| Nuclear Proteins | 1 | 1999 | 3343 | 0.020 |
Why?
|
| DNA Primers | 1 | 2010 | 1399 | 0.020 |
Why?
|
| DNA, Viral | 1 | 2010 | 694 | 0.020 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 716 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 1 | 2009 | 769 | 0.020 |
Why?
|
| Linear Models | 1 | 2009 | 1085 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 12873 | 0.020 |
Why?
|
| Antibodies, Neutralizing | 1 | 2010 | 541 | 0.020 |
Why?
|
| Brain | 1 | 2019 | 4113 | 0.020 |
Why?
|
| Recombinant Proteins | 2 | 2000 | 2927 | 0.020 |
Why?
|
| Cell Line | 1 | 2012 | 5114 | 0.020 |
Why?
|
| Base Sequence | 1 | 2010 | 4917 | 0.010 |
Why?
|
| Gene Expression | 1 | 2012 | 3570 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 2010 | 1320 | 0.010 |
Why?
|
| Genetic Therapy | 1 | 2010 | 1616 | 0.010 |
Why?
|
| Cytokines | 1 | 2010 | 2809 | 0.010 |
Why?
|
| Receptor, ErbB-2 | 1 | 2010 | 2518 | 0.010 |
Why?
|
| Liver | 1 | 2010 | 2961 | 0.010 |
Why?
|
| Biological Transport, Active | 1 | 1999 | 131 | 0.010 |
Why?
|
| Capsid Proteins | 1 | 1999 | 185 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1999 | 1258 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2010 | 14551 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2000 | 1555 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2010 | 11538 | 0.000 |
Why?
|